FDA Drug Recalls

Recalls / Class III

Class IIID-0080-2024

Product

Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 Fl oz) bottles, Rx only, Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054, NDC 42799-217-01

Brand name
Opium Tincture Deodorized
Generic name
Morphine
Active ingredient
Morphine
Route
Oral
NDC
42799-217
Affected lot / code info
Lot#: 23ZCP1, Exp. Date 02/22/2026;Lot #:23ZDR1, Exp. Date 03/09/2026

Why it was recalled

Subpotent Drug

Recalling firm

Firm
Edenbridge Pharmaceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Upper Pond Rd, Ste 250, Parsippany, New Jersey 07054-1050

Distribution

Quantity
4548 bottles
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2023-10-20
FDA classified
2023-10-30
Posted by FDA
2023-11-08
Terminated
2024-08-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0080-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Opium Tincture Deodorized · FDA Drug Recalls